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The quest for mixed venous oxygenation (S mv O 2 ).
In the latter part of the 19 th Century, Adolf Fick (1821-1901) proposed his famous Fick's Principle, whereby cardiac output could be estimated by calculating the ratio of systemic O 2 consumption (VO 2 ) sys , measured from the expired gases, to the arterio-venous O 2 
Where [Hb] indicates the haemoglobin concentration (gram dL -1 ).
Since, at the time, there was no safe way to obtain access to pulmonary artery blood in humans, the cardiac output could not be calculated by Fick's Principle. This situation changed in 1929 when Werner Forssman demonstrated that a catheter could be passed safely into the right atrium. One year later, Otto Klein (1881 Klein ( -1968 became the first individual to use Forssman's technique to measure cardiac output by Fick's Principle. A decade later, André Cournand and Dickinson Richards perfected the technique of right heart catheterisation and reported that they were able to leave a pulmonary artery catheter in place for a length of time with no harm to the patient. In 1970, Jeremy Swan (1922 Swan ( -2005 and William Ganz ) developed a flow-directed pulmonary artery catheter (PAC) that could be inserted into the pulmonary artery without fluoroscopic guidance, allowing for ready and safe access to mixed venous blood in the ICU (1).
Paradoxically, the PAC also eliminated the need to measure S mv O 2 , since cardiac output now could be measured accurately by thermo-dilution. On the other hand, the unhindered access to pulmonary artery blood resulted in S mv O 2 becoming one of the most commonly monitored physiological measures in the ICU, although its clinical utility remains a topic of intense and continuing debate. This review will discuss the utility, or lack thereof, of S mv O 2 and of central venous blood O 2 saturation (S cv O 2 ) in the care of the critically ill patient. The poor correlation between S mv O 2 and Q has been noted in studies performed under diverse clinical conditions, including the induction of anaesthesia (6), congestive heart failure (7), and septic shock (8) . Using continuous measures of S mv O 2 that were obtained by reflectance spectrophotometry to calculate Q has also proven disappointing, because it was found to ac- curately predict changes in cardiac output only 50% of the time (9) . An important assumption of Krogh's model is the equivalence between end-capillary and venous blood PO 2 . This assumption provides the physiological basis for the notion that venous SO 2 is a marker of tissue oxygenation. Extension of the Kroghian theory to the body as a whole provides the foundation for assuming that S mv O 2 is a marker of global tissue oxygenation. This is a precarious and often incorrect assumption, since it fails to consider the intricate macro-and microcirculatory adjustments that are attendant to sepsis and hypoxaemia.
The elegant simplicity of Krogh's model provides a lucid physiological construct for the process of tissue oxygenation, but fails to account for the spatial and temporal heterogeneity of the microcirculation. Second order processes, including capillary recruitment, O 2 diffusion between adjacent capillaries, time-dependent haemoglobin O 2 unloading, and perpendicular and counter-current flow combine to produce a remarkably homogeneous distribution of tissue, one lacking 'lethal corners'. It is possible that the intestinal villi and the renal medulla, organs characterised by a peculiar vascular arrangement of counter-current flow, may have regions akin to the 'lethal corner', where cells exist on the edge of hypoxia, vulnerable to even mild ischaemic or hypoxic insults (12). Another factor conflicting with the use of S mv O 2 as a marker of peripheral organ oxygenation is that S mv O 2 results from mixing the venous effluents of all organs in the right heart chambers. As such, it can be defined as the flow-weighted average of all venous effluents SO 2 as: However, as we have noted in septic and general ICU patients, the relationship of post-operative complications to low S cv O 2 measurements is not clear cut. Greater mortality rates also have been noted in patients undergoing elective cardiac surgery (n=205) with either low (<61%) or high (>77%) S cv O 2 values (37). A study in septic shock patients showed no difference in mortality when therapy aimed at increasing lactate clearance to ≥10% was compared to that of raising S cv O 2 to ≥70% (n=150 each group) (39) . A subsequent study by the same investigators (40) (n=203) showed that achieving a lactate clearance of ≥10% was more strongly associated with survival than achieving a S cv O 2 value of ≥70%.
Decreases in S mv O 2 or S cv O 2 levels are prone to reflect increased extraction by the respiratory muscles, therefore, monitoring these variables during the process of weaning patients from mechanical ventilation appears to be useful. A study in haemodynamically stable ICU patients undergoing weaning (n=73) found that a decrease in S cv O 2 > 4.5% was the only independent predictor of re-intubation (41). When S mv O 2 was monitored continuously, weaning failure (n=8) was associated with progressive declines in S mv O 2 , in contrast to weaning success (n=11), where the S mv O 2 did not change (42) .
S cv O 2 as a guide to resuscitation in sepsis
The concept of pathologic supply dependency during sepsis arose from the confluence of two observations. The first observation is that [Lac] usually increases in sepsis, which may be interpreted as the activation of anaerobic glycolysis by tissue hypoxia. The second observation is that increasing (DO 2 ) Sys in septic patients is usually associated with greater (VO 2 ) Sys (43) . These observations gave rise to the concept of 'pathologic supply dependency', implying that septic tissues experience a 'covert' hypoxic condition (44) , which is unmasked by increases in (DO 2 ) Sys accomplished either by a dobutamine-mediated rise in cardiac output (45) or by the transfusion of blood (46) . A clinical trial tested this hypothesis in a heterogeneous ICU population in which one group (n=253) was targeted to achieve a high cardiac index and another (n=257) was set to maintain S mv O 2 at ≥70%. Neither group, however, showed improved survival when compared to the control group (47) .
Several years later, a study was conducted in septic shock patients (n=263) that emphasised alacrity in therapeutic response. Treatment was dictated by a resuscitation algorithm called Early Goal Directed Therapy (EGDT) implemented during the patient's initial 6 hours in the hospital (48) , in which therapy was in part guided by S cv O 2 measured continuously with a spectrophotometric central venous catheter. Among the treatment arms of the EGDT algorithm was the maintenance of S cv O 2 ≥70% mediated by increases in (O 2 ) Sys with fluids, RBC transfusions and dobutamine. The study showed a substantially lower mortality (30.5% vs. 46.5%) in patients treated with EGDT.
Three large prospective randomised studies enrolling a total of 4,183 patients tested the hypothesis that EGDT improves ICU survival in septic patients. All three of these trials, The Protocolized Care for Early Septic Shock (ProCESS) (49) , the Autralasian Resuscitation Sepsis Evaluation (ARISE) (50) , and the Protocolised Management of Sepsis (ProMISe) (51) have failed to show a survival advantage by implementing EGDT.
Without delving into all possible causes leading to the divergent outcomes of the initial EGDT study and the recent trials, it may be instructive to examine one aspect of these trials heretofore ignored. It concerns the low initial S cv O 2 values reported in the initial. EGDT study of 49±11%. By most standards these are very low S cv O 2 values, and quite different from those found in a Dutch multicentre study that reported <1% of septic patients having S cv O 2 <50% within 6 hours of hospital admission (52) . Moreover, initial S cv O 2 values were 71±13% in the ProCESS, 73±11 % in the ARISE, and 65±20% in the ProMISe study. Figure 4 depicts the Gaussian functions corresponding to these initial S cv O 2 values. Obviously, the S cv O 2 distribution reported in the EGDT trial is substantially different from the others (p<0.001). This observation suggests that the cohort enrolled in the EGDT trial differed fundamentally from those enrolled in the subsequent negative trials.
A possible explanation for this discrepancy may be found by noting the location of the catheter in the SVC where S cv O 2 is measured. The central venous catheter should lie with its tip in the SVC, below the anterior first rib, and above the RA. This places the infrared spectrophotometer fibreoptic sensor just below the opening of the azygos vein, a unilateral vessel carrying blood from the posterior intercostal muscle and the diaphragmatic veins. Patients in the original EGDT study experienced considerable respiratory distress, with 53% requiring invasive mechanical ventilation, compared to the values of 26%, 20%, and 22% for patients in the ProCESS, ARISE, and ProMISe trials, respectively. Increased work by the respiratory muscles, particularly by the intercostal muscles, results in blood of very low O 2 saturation being discharged by the azygos vein into the SVC, which is in close proximity to the oximeter sensor. Therefore, it is likely that the S cv O 2 values reported in the EGDT trial reflected increased work of breathing and not global tissue hypoxia, further suggesting that the correct therapy was by way of mechanical ventilation, not RBC transfusion or dobutamine infusion. Supporting this hypothesis was a study of septic patients showing increases in S cv O 2 from 64% to 71%, before and after applying mechanical ventilation (53) .
To summarise, it appears that S cv O 2 -guided resuscitation does not improve the survival of septic patients. On the other hand, the early application of some treatment modalities, such as the early administration of antibiotics, low tidal volume mechanical ventilation, and rapid fluid infusion with the reversal of hypotension can improve survival in cases of severe sepsis or septic shock (54) .
Conclusion
The ideal ICU monitored variable must meet each of the following parameters: (1) easy to measure; (2) easy to interpret; (3) amenable to treatment; and (4) measured non-invasively. Pulse oximetry is the quintessential monitoring device that meets all these criteria. S cv O 2 monitoring, on the other hand, falls far short of this expectation. S cv O 2 is relatively easy to measure, either intermittently or continuously, with a fiberoptic catheter. However, due to its invasiveness, the decision to insert a central venous catheter solely for the purpose of measuring S cv O 2 should be tempered by the risk associated with the procedure.
Changes in S mv O 2 are inversely related to changes in systemic ERO 2 . The same concept applies to S cv O 2 regarding upper body organs. As previously reviewed, however, S cv O 2 is not easy to interpret. Experienced clinicians might also be confused by the information conveyed by S cv O 2 . Perhaps the continuous monitoring of S mv O 2 or S cv O 2 is useful in selected cases where the patient's pathophysiology is well understood, such as when there is cardiomyopathy with reduced cardiac output. This is not the case in most other conditions that affect critically ill individuals, particularly in cases of severe sepsis, in which both high and low S mv O 2 or S cv O 2 values carry a dire prognosis.
Lastly, not knowing the pathophysiological processes responsible for alterations in S cv O 2 in sepsis, as well as lacking a clearly defined therapeutic response, greatly diminish the clinical utility of this monitored variable. Whether the aim is to decrease O 2 consumption by mechanical ventilation or increase O 2 delivery by transfusing RBCs or infusing dobutamine, it cannot be easily discerned from measures of S cv O 2 .
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